Dean J Mitchell Theravance Biopharma, Inc. (TBPH) insider trading activity

TBPH Quotes by TradingView

Dean J Mitchell is of Theravance Biopharma, Inc.. Currently has a direct ownership of 80,555 shares of TBPH, which is worth approximately $772,522. The most recent transaction as insider was on May 08, 2024, when has been sold 10,537 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.6K
0% 3M change
15.05% 12M change
Total Value Held $772,522

DEAN J MITCHELL Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 08 2024
BUY
Grant, award, or other acquisition
-
10,537 Added 11.57%
80,555 Ordinary Shares
May 02 2023
BUY
Grant, award, or other acquisition
-
9,132 Added 11.54%
70,018 Ordinary Shares
Apr 26 2022
BUY
Grant, award, or other acquisition
-
9,852 Added 13.93%
60,886 Ordinary Shares
Apr 27 2021
BUY
Grant, award, or other acquisition
-
9,828 Added 16.15%
51,034 Ordinary Shares

Also insider at

IMGN
ImmunoGen, Inc. Healthcare
Director
PGEN
PRECIGEN, INC. Healthcare
Director
PRAX
Praxis Precision Medicines, Inc. Healthcare
Director
KNTE
Kinnate Biopharma Inc. Healthcare
DJM

Dean J Mitchell

Waltham, MA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TBPH